01612 VINCENT MED
Trading Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 2.16X | Oper Margin | 10.0% |
---|---|---|---|
LT Debt/Equity | 10.4% | Net Margin | 8.6% |
Total Debt/Equity | 17.2% | Return on Equity | 12.0% |
Price/Book | 0.75X | Return on Assets | 7.5% |
(HKD 0.660) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | 69.17 | 57.28 | -17.40 | 60.70 | 216.87 |
---|---|---|---|---|---|
Net Profit Growth (%) | +20.8 | +429.2 | -128.7 | -72.0 | +1,781.7 |
Earnings Per Share (HKD) | 0.108 | 0.089 | -0.027 | 0.093 | 0.338 |
Earnings Per Share Growth (%) | +21.2 | +433.5 | -128.7 | -72.6 | +1,769.6 |
Dividend Per Share (HKD) | 0.033 | 0.028 | 0.025 | 0.045 | 0.110 |
P/E* (X) | 6.14 | 7.44 | N/A | 7.11 | 1.95 |
Yield (%) | 5.00 | 4.17 | 3.79 | 6.82 | 16.67 |
Dividend Share (%) | 30.70 | 31.00 | N/A | 48.49 | 32.51 |
Book NAV (HKD) | 0.886 | 0.829 | 0.762 | 0.914 | 0.940 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(HKDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 800.963 | 717.973 | +11.6 | 629.242 |
Operating Result | 78.307 | 63.645 | +23.0 | -14.473 |
Associates | -0.328 | 2.817 | -111.6 | -1.664 |
Profit Before Taxation | 77.979 | 66.915 | +16.5 | -15.516 |
Taxation | 7.083 | 8.707 | -18.7 | 2.874 |
Profit /( Loss) After Taxation | 70.896 | 58.208 | +21.8 | -18.39 |
Minority Interests | 1.729 | 0.933 | +85.3 | -0.992 |
Net Profit | 69.167 | 57.275 | +20.8 | -17.398 |
Earnings Per Share () | 0.1075 | 0.0887 | +21.2 | -0.0266 |
Dividend Per Share () | 0.0330 | 0.0275 | +20.0 | 0.0250 |
Announcement Date | 2025-03-19 | 2024-03-20 | NA | 2023-03-22 |
* Annualised
Last Update Time: 2025-07-22 21:40:25